| Trial Identifier: | 0598-CL-0101 |
| Sponsor: | Astellas Pharma Global Development, Inc. |
| Start Date: | September 2020 |
| Primary Completion Date: | January 2023 |
| Study Completion Date: | January 2023 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| United States of America, CA | Torrance, CA, United States of America, 90503 |
| United States of America, California | Palo Alto, California, United States of America, 94304 |
| United States of America, Florida | Boca Raton, Florida, United States of America, 33487 |
| United States of America, Indiana | New Albany, Indiana, United States of America, 47150 |
| United States of America, Kentucky | Louisville, Kentucky, United States of America, 40220 |
| United States of America, Michigan | Ann Arbor, Michigan, United States of America, 48109 |
| United States of America, NC | Winston-Salem, NC, United States of America, 27103 |
| United States of America, North Carolina | Matthews, North Carolina, United States of America, 28105 |
| United States of America, South Carolina | Orangeburg, South Carolina, United States of America, 29118 |
| United States of America, Virginia | Richmond, Virginia, United States of America, 23235 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company